Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Schäufele TJ"'
Autor:
Friedel J; Institute of Clinical Pharmacology, Goethe University, Frankfurt, Germany., Pierre S; Institute of Clinical Pharmacology, Goethe University, Frankfurt, Germany., Kolbinger A; Institute of Clinical Pharmacology, Goethe University, Frankfurt, Germany., Schäufele TJ; Institute of Clinical Pharmacology, Goethe University, Frankfurt, Germany., Aliraj B; Institute of Biochemistry I, Faculty of Medicine, Goethe University, Frankfurt, Germany., Weigert A; Institute of Biochemistry I, Faculty of Medicine, Goethe University, Frankfurt, Germany., Scholich K; Institute of Clinical Pharmacology, Goethe University, Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Frankfurt, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Apr 30; Vol. 15, pp. 1353922. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).
Autor:
Schäufele TJ; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany., Kolbinger A; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany., Friedel J; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany., Gurke R; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Frankfurt, Germany., Geisslinger G; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Frankfurt, Germany., Weigert A; Institute of Biochemistry I, Goethe University Frankfurt, Frankfurt, Germany., Pierre S; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany., Scholich K; Institute of Clinical Pharmacology, Goethe University Frankfurt, Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.; Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, Frankfurt, Germany.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2024 Apr; Vol. 181 (7), pp. 1051-1067. Date of Electronic Publication: 2023 Nov 22.
Eosinophil-derived IL-4 is necessary to establish the inflammatory structure in innate inflammation.
Autor:
Kolbinger A; Institute of Clinical Pharmacology, Goethe-University Frankfurt, Frankfurt, Germany., Schäufele TJ; Institute of Clinical Pharmacology, Goethe-University Frankfurt, Frankfurt, Germany., Steigerwald H; Institute of Clinical Pharmacology, Goethe-University Frankfurt, Frankfurt, Germany., Friedel J; Institute of Clinical Pharmacology, Goethe-University Frankfurt, Frankfurt, Germany., Pierre S; Institute of Clinical Pharmacology, Goethe-University Frankfurt, Frankfurt, Germany., Geisslinger G; Institute of Clinical Pharmacology, Goethe-University Frankfurt, Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Frankfurt, Germany., Scholich K; Institute of Clinical Pharmacology, Goethe-University Frankfurt, Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Frankfurt, Germany.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2023 Feb 08; Vol. 15 (2), pp. e16796. Date of Electronic Publication: 2022 Dec 21.
Autor:
Kolbinger A; Institute of Clinical Pharmacology, pharmazentrum frankfurt Goethe-University, D-60590 Frankfurt am Main, Germany., Kestner RI; Department of Neurology, Hospital of the Goethe University Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.; Institute of Pharmacology and Toxicology, pharmazentrum frankfurt Goethe-University, D-60590 Frankfurt am Main, Germany., Jencio L; Department of Neurology, Hospital of the Goethe University Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany., Schäufele TJ; Institute of Clinical Pharmacology, pharmazentrum frankfurt Goethe-University, D-60590 Frankfurt am Main, Germany., Vutukuri R; Institute of Pharmacology and Toxicology, pharmazentrum frankfurt Goethe-University, D-60590 Frankfurt am Main, Germany., Pfeilschifter W; Institute of Pharmacology and Toxicology, pharmazentrum frankfurt Goethe-University, D-60590 Frankfurt am Main, Germany.; Department of Neurology and Clinical Neurophysiology, Municipal Hospital Lüneburg, D-21339 Lüneburg, Germany., Scholich K; Institute of Clinical Pharmacology, pharmazentrum frankfurt Goethe-University, D-60590 Frankfurt am Main, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany.; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany.
Publikováno v:
Cells [Cells] 2022 May 17; Vol. 11 (10). Date of Electronic Publication: 2022 May 17.
Autor:
El-Hindi K; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Brachtendorf S; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Hartel JC; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.; Department of Life Sciences, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Oertel S; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Birod K; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Merz N; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Trautmann S; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Thomas D; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 60596 Frankfurt, Germany., Weigert A; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Schäufele TJ; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Scholich K; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany., Schiffmann S; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 60596 Frankfurt, Germany., Ulshöfer T; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 60596 Frankfurt, Germany., Utermöhlen O; Center for Molecular Medicine Cologne, Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, 50935 Cologne, Germany., Grösch S; Institute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 60596 Frankfurt, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Feb 07; Vol. 23 (3). Date of Electronic Publication: 2022 Feb 07.
Autor:
Kornstädt L; Institute of Clinical Pharmacology, University Hospital Goethe-University Frankfurt, Frankfurt, Germany., Pierre S; Institute of Clinical Pharmacology, University Hospital Goethe-University Frankfurt, Frankfurt, Germany., Weigert A; Faculty of Medicine, Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany., Ebersberger S; Institute of Molecular Biology gGmbH, Mainz, Germany., Schäufele TJ; Institute of Clinical Pharmacology, University Hospital Goethe-University Frankfurt, Frankfurt, Germany., Kolbinger A; Institute of Clinical Pharmacology, University Hospital Goethe-University Frankfurt, Frankfurt, Germany., Schmid T; Faculty of Medicine, Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany., Cohnen J; Institute of Clinical Pharmacology, University Hospital Goethe-University Frankfurt, Frankfurt, Germany., Thomas D; Institute of Clinical Pharmacology, University Hospital Goethe-University Frankfurt, Frankfurt, Germany., Ferreirós N; Institute of Clinical Pharmacology, University Hospital Goethe-University Frankfurt, Frankfurt, Germany., Brüne B; Faculty of Medicine, Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany.; Project Group Translational Medicine and Pharmacology, Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Frankfurt am Main, Germany., Ebersberger I; Department for Applied Bioinformatics, Institute for Cell Biology and Neuroscience, Goethe-University Frankfurt, Frankfurt, Germany.; Senckenberg Biodiversity and Climate Research Centre (S-BIKF), Frankfurt am Main, Germany.; LOEWE Centre for Translational Biodiversity Genomics (TBG), Frankfurt am Main, Germany., Scholich K; Institute of Clinical Pharmacology, University Hospital Goethe-University Frankfurt, Frankfurt, Germany.; Project Group Translational Medicine and Pharmacology, Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Frankfurt am Main, Germany.; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Frankfurt am Main, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Feb 12; Vol. 11, pp. 607048. Date of Electronic Publication: 2021 Feb 12 (Print Publication: 2020).
Autor:
Kropp KN; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany., Schäufele TJ; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany., Fatho M; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany., Volkmar M; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz-Institute for Translational Oncology Mainz (HI-TRON Mainz)-a Helmholtz institute by DKFZ, Mainz, Germany., Conradi R; Transfusion Center, University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany., Theobald M; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany., Wölfel T; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany., Wölfel C; Internal Medicine III, University Cancer Center (UCT), Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany.
Publikováno v:
PloS one [PLoS One] 2020 Sep 09; Vol. 15 (9), pp. e0238875. Date of Electronic Publication: 2020 Sep 09 (Print Publication: 2020).